Infection associated with hemodialysis and peritoneal dialysis catheters;Infecciones asociadas a los catéteres utilizados para la hemodiálisis y la diálisis peritoneal

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 26, Issue 8, 2008, Pages 518-526

  Fariñas, María Carmen ^a   García Palomo, José Daniel ^a   Gutiérrez Cuadra, Manuel ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Catheter; Dialysis; Infection

Indexed keywords

AMIKACIN; AMOXICILLIN; AMPHOTERICIN B LIPID COMPLEX; AMPICILLIN; BETA LACTAM; CASPOFUNGIN; CEFALEXIN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; CLARITHROMYCIN; CLOXACILLIN; DAPTOMYCIN; FLUCLOXACILLIN; FLUCONAZOLE; GENTAMICIN; IMIPENEM; ISONIAZID; LEVOFLOXACIN; LINEZOLID; MEROPENEM; METICILLIN; METRONIDAZOLE; OFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; PYRAZINAMIDE; TEICOPLANIN; TOBRAMYCIN; UNINDEXED DRUG; VANCOMYCIN;

ANTIMICROBIAL THERAPY; CATHETER INFECTION; CENTRAL VENOUS CATHETER; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; HEMODIALYSIS; HUMAN; NONHUMAN; PATHOGENESIS; PERITONEAL DIALYSIS; PERITONITIS; RECOMMENDED DRUG DOSE; REVIEW; STAPHYLOCOCCUS AUREUS;

EID: 56249133325     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1157/13127459     Document Type: Review

References (50)

1. López Revuelta K, Saracho R, García López F, Gentil MA, Castro P, Castilla J, et al. Informe de diálisis y trasplante año 2001 de la Sociedad Española de Nefrología y Registros Autonómicos. Nefrologia. 2004; 24:21-33.
2. Rodríguez Hernández JA, González Parra E, Julián Gutiérrez JM, Segarra Medrano A, Almirante B, Martínez MT, et al. Guías de acceso vascular en hemodiálisis. Nefrologia. 2005;25 Suppl 1:3-97.
3. Rodríguez JA, López Pedret J, Piera L. El acceso vascular en España: análisis de su distribución, morbilidad y sistemas de monitorización. Nefrologia. 2001;21:45-51.
4. Pisoni RL, Young EW, Dykstra DM, Greewood RN, Hecking E, Gillespi B, et al. Vascular access use in Europe and the United States: results from the DOPPS. Kidney Int. 2002;61:305-16.
5. Taylor G, Gravel D, Johnston L, Embil J, Holton D, Paton S. Incidence of bloodstream infection in multicenter inception cohorts of hemodialysis patients. Am J Infect Control. 2004;32:155-60.
6. Astor BC, Eustace JZ, Powe NR, Klag MJ, Fink NE, Coresh J; the CHOICE Study. Type of vascular access and survival among incident hemodialysis patients: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. J Am Soc Nephrol. 2005;16:1449-55.
7. Lee T, Barker J, Allon M. Tunneled catheters in hemodialysis patients: Reasons and subsequent outcomes. Am J Kidney Dis. 2005;46:501-8.
8. Álvarez Navascués R, Quiñones L, Guerediaga J. Catéter de Tesio permanente para la realización de hemodiálisis crónica: nuestra experiencia en un hospital comarcal. Nefrologia. 2005;25:407-11.
9. Mauro MA, Jaques PF. Insertion of long-term hemodialysis catheters by interventional radiologist: the trend continues. Radiology. 1996;198:315-7.
10. Perini S, LaBerge JM, Peral JM, Santiesteban HL, Ives HE, Omachi RS, et al. Tesio Catheter: Radiologically Guided Placement, Mechanica, Performance, and Adequacy of Delivered Dialysis. Radiology. 2000;215:129-37.
11. Di Iorio B. Central Venous Catheter in hemodialysis: an actual conundrum without solutions. J Vasc Access. 2002;3:174-6.
12. Butterly DW, Schwab SJ. Dialysis access infections. Curr Opin Nephrol Hypertens. 2000;9:631-5.
13. Oliver MJ, Callery SM, Thorpe KE, Schwab SJ, Churchill DN. Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: a prospective study. Kidney Int. 2000;58:2543-5.
14. Saad TF. Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis. 1999;34:1114-24.
15. Stevenson KB, Hannah EL, Lowder CA, Adcox MJ, Davidson RL, Mallea MC, et al. Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: Predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis. 2002;39:549-55.
16. De Cicco M, Campisi C, Matovic M. Central venous catheter related bloodstream infections: Pathogenesis factors, new perspectives in prevention and early diagnosis. J Vasc Access. 2003;4:83-91.
17. Vila J, Soriano A, Mensa J. Molecular basis of microbial adherence to prosthetic materials. Role of biofilms in prosthesis-associated infection. Enferm Infecc Microbiol Clin. 2008;26:48-54.
18. Adeniyi OA, Tzamaloukas AH. Relation between access-related infection and pre-infection serum albumin concentration in patients on chronic hemodialysis. Hemodial Int. 2003;7:304-10.
19. Descamps-Latscha B, Drüeke T, Witko-Sarat V. Dialysis-induced oxidative stress: biological aspects, clinical consequences, and therapy. Semin Dial. 2001;14:193-9.
20. Descamps-Latscha B, Jungers P, Witko-Sarat V. Immune system dysregulation in uremia: Role of oxidative stress. Blood Purific. 2002;20:481-4.
21. Meier P, Dayer E, Blanc E, Wauters JP. Early T-cell activation correlation with expression of apoptosis markers in patients with end stage renal disease. J Am Soc Nephrol. 2002;13:204-12.
22. Nucifora G, Badano LP, Viale P, Gianfagna P, Allocca G, Montanaro D, et al. Infective endocarditis in chronic haemodialysis patients: an increasing clinical challenge. Eur Heart J. 2007;28:2307-12.
23. Kamalakannan D, Pai RM, Johnson LB, Gardin JM, Saravolatz LD. Epidemiology and clinical outcomes of infective endocarditis in hemodialysis patients. Ann Thorac Surg. 2007;83:2081-6.
24. Nori US, Manoharan A, Thornby JI, Yee J, Parasuraman R, Ramanathan V. Mortality risk factors in chronic haemodialysis patients with infective endocarditis. Nephrol Dial Transplant. 2006;21:2184-90.
25. Lok CE. Avoiding trouble down the line: the management and prevention of hemodialysis catheter-related infections. Adv Chronic Kidney Dis. 2006;13:225-44.
26. Sullivan R, Samuel V, Le C, Khan M, Alexandraki I, Cuhaci B, et al. Hemodialysis vascular catheter-related bacteremia. Am J Med Sci. 2007;334:458-65.
27. Nassar GM, Ayus JC. Infectious complications of the hemodialysis access. Kidney Int. 2001;60:1-13.
28. Cisneros-Herreros JM, Cobo-Reinoso J, Pujol-Rojo M, Rodríguez- Baño J, Salavert-Lletí M. Guidelines for the diagnosis and treatment of patients with bacteriemia. Guidelines of the Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Enferm Infecc Microbiol Clin. 2007;25:111-30.
29. León C, Ariza J; SEIMC. SEMICYUC Guidelines for the treatment of short-term intravascular catheter-related infections in adults; SEIMC-SEMICYUC Consensus Conference Enferm Infecc Microbiol Clin. 2004;22:92-101.
30. Catton JA, Dobbins BM, Kite P, Wood JM, Eastwood K, Sugden S, et al. In situ diagnosis of intravascular catheter-related bloodstream infection: A comparison of quantitative culture, differential time to positivity, and endoluminal brushing. Crit Care Med. 2005;33:787-91.
31. Mermel LA, Farr BM, Sherertz RJ, Raad II, O'Grady N, Harris JS, Craven DE. Guidelines for the Management of Intravascular Catheter-Related Infections. Clin Infect Dis. 2001;32:1249-72.
32. León C, Bouza B, Fariñas C, Fortum J, García- Sánchez E, Liñares J, et al. Update on vascular catheter-related infections. Enf Infec Microbiol Clin. 2007;25 Suppl 1:37-46.
33. Humar A, Ostromecki A, Direnfeld J, Marshall JC, Lazar N, Houston PC, et al. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection. Clin Infect Dis. 2000;31:1001-7.
34. Tokars JI, Arduino MJ, Alter MJ. Infection control in hemodialysis units. Infect Dis Clin North Am. 2001;15:797-812.
35. Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis. 2008;47:83-93.
36. Jaffer Y, Selby NM, Taal MW, Fluck RJ, McIntyre CW. A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. Am J Kidney Dis. 2008;51:233-41.
37. Band JD. Infections associated with peritoneal dialysis. En: Mayhall CG, editor. Hospital epidemiology and infection control. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2004. p. 1159-72.
38. Gupta B, Bernardini J, Piraino B. Peritonitis associated with exit site and tunnel infections. Am J Kidney Dis. 1996;28:415-9.
39. Montenegro J, Molina A, Rodríguez-Palomares JR, González Parra E. Peritonitis en diálisis peritoneal. Nefrologia. 2006;26 Supl 4:115-31.
40. Aslam N, Bernardini J, Fried L, Burr R, Piraino B. Comparison of infectious complications between incident hemodialysis and peritoneal dialysis patients. Clin J Am Soc Nephrol. 2006;1:1226-33.
41. Teixidó J, Arias N, Tarrats L, Romero R. Patrón microbiológico de la infección del catéter peritoneal: ¿aumento de Corynebacterium sp.? Nefrologia. 2007;27:350-8.
42. Strippoli GF, Tong A, Johnson D, Schena FP, Craig JC. Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systematic review of randomized, controlled trials. J Am Soc Nephrol. 2004;15:2735-46.
43. Strippoli GF, Tong A, Johnson D, Schena FP, Craig JC. Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials. Am J Kidney Dis. 2004;44:591-603.
44. Szeto CC, Leung CB, Chow KM, Kwan BC, Law MC, Wang AY, et al. Change in bacterial aetiology of peritoneal dialysis-related peritonitis over 10 years: experience from a centre in South-East Asia. Clin Microbiol Infect. 2005;11:837-9.
45. Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, et al; ISPD Ad hoc Advisory Committee. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int. 2005;25:107-31.
46. Keane WF, Bailie GR, Boeschoten E, Goakl R, Golper TA, Holmes CJ, et al. ISPD guidelines/recommendations: adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int. 2000;20:396-411.
47. Twardowski ZJ, Prowant BF. Current approach to exit-site infections in patients on peritoneal dialysis. Nephrol Dial Transplant. 1997;12:1284-8.
48. Flanigan M, Gokal R. Peritoneal catheters and exit-site practices toward optimum peritoneal access: a review of current developments. Perit Dial Int. 2005;25:132-9.
49. Wu YM, Tsai MK, Chao SH, Tsai TJ, Chang KJ, Lee PH. Surgical management of refractory exit site/tunnel infection of tenckhoff catheter: technical innovations of partial replantation. Perit Dial Int. 1999;19:451-5.
50. Schiffl H, Mücke C, Lang SM. Exit-site infections by non-diphteria corynebacteria in CAPD. Perit Dial Intern. 2004;24:454-9.